Venetoclax-based non-intensive combinations for relapsed/refractory acute myeloid leukaemia-Real-world data from a UK-wide programme
Wood, Henry O'Nions, Jenny Chan, Wei Yee Borg, Albert Veitch, Scott Elder, Patrick Jain, Manish Aries, James Leak, Steven Mitchell, Emily
Wood, Henry
O'Nions, Jenny
Chan, Wei Yee
Borg, Albert
Veitch, Scott
Elder, Patrick
Jain, Manish
Aries, James
Leak, Steven
Mitchell, Emily
Affiliation
King's College Hospital NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; Imperial College Healthcare NHS Trust; Guy's and St Thomas' NHS Foundation Trust; The Royal Marsden NHS Foundation Trust; Leeds Teaching Hospitals NHS Trust; Barts Health NHS Trust; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; King's College London; University of Sydney; University Hospitals Bristol and Weston NHS Foundation Trust; University Hospitals Birmingham NHS Foundation Trust; Cardiff University; University of Warwick
Other Contributors
Publication date
2025-05-20
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available
Citation
Wood H, O'Nions J, Chan WY, Borg A, Veitch S, Elder P, Jain M, Aries J, Leak S, Mitchell E, Pavlu J, Othman J, Dillon R, Mehta P, Murthy V, Knapper S, Potter V, Copland M, Craddock C, Krishnamurthy P. Venetoclax-based non-intensive combinations for relapsed/refractory acute myeloid leukaemia-Real-world data from a UK-wide programme. Br J Haematol. 2025 May 20. doi: 10.1111/bjh.20149. Epub ahead of print.
Type
Correspondence